2018
DOI: 10.1371/journal.pone.0199693
|View full text |Cite
|
Sign up to set email alerts
|

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema

Abstract: PurposeTo evaluate changes in colour vision following intravitreal injection of Dexamethasone implant (Ozurdex) in patients with diabetic macular oedema (DMO). Both red-green (RG) and yellow-blue (YB) chromatic sensitivity were assessed using the Colour Assessment & Diagnosis (CAD) test which isolates the use of colour signals and provides age-corrected, statistical limits for normal trichromats. To determine whether colour changes and visual acuity (VA) post-treatment relate to central sub-field retinal thick… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 35 publications
0
10
0
Order By: Relevance
“…This was the case for participants with hypertension who rarely exhibit significant loss of spatial vision. However, those diagnosed with diabetes were excluded since this systemic condition is known to affect several aspects of vision 69–73 Absence of current signs of ocular disease, conventional or refractive laser surgery, corneal dystrophies or lens extraction.…”
Section: Methodsmentioning
confidence: 99%
“…This was the case for participants with hypertension who rarely exhibit significant loss of spatial vision. However, those diagnosed with diabetes were excluded since this systemic condition is known to affect several aspects of vision 69–73 Absence of current signs of ocular disease, conventional or refractive laser surgery, corneal dystrophies or lens extraction.…”
Section: Methodsmentioning
confidence: 99%
“…Interestingly, Dex implant was demonstrated to be effective even in improving other functional aspects, such as color vision. The analysis of both red-green (RG) and yellow-blue (YB) color thresholds variation after Dex implant was performed in 14 patients with DME [85]. Twenty-four weeks after injection, the RG threshold improved significantly, while YB ones remained substantially unchanged after treatment.…”
Section: Evidence Of the Efficacy Of Dex In Diabetic Macular Edemamentioning
confidence: 99%
“…The visual function is also affected 1,2,6,7 . Younger adults may also be affected by systemic diseases 8,9 . Glaucoma, cataract, macular degeneration, and diabetes are the common causes of acquired color vision defects 1…”
Section: Introductionmentioning
confidence: 99%